Back to Screener

Healthcare

argenx SE(ARGNF)

Live Price

Offline

$900.00

+0.00% today

1Y Change

+64.48%

Window

Jun 30, 2025 โ†’ Jun 23, 2026

Market Cap
$50.01B
Revenue Growth
+97.3%
EPS Growth
+57.6%
Dividend Yield
0.0%

Coverage: 253 bars ยท Jun 30, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

argenx SE (ARGNF) is a Healthcare stock with a market cap of $50.01B. The stock last traded around $900.00 and up 64.5% across the available one-year price window (Jun 30, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +97.3%, EPS growth of +57.6%, a dividend yield of 0.0%. What stands out right now is revenue +97.3%, EPS +57.6%, free cash flow +1136.0% with operating margin 25.6% and ROIC 11.7%. Valuation already assumes a fairly strong business story at P/E 44.0 and price/sales 14.8. Stock Foundry combines ARGNF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

ARGNF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

ARGNF is 45.75 pts ahead over the shared 1Y window.

ARGNF had 9.24 pts deeper max drawdown than SPY.

ARGNF beat SPY in 1 of 2 calendar years shown and trailed in 1.

ARGNF

+64.48%

Normalized return

SPY

+18.73%

S&P 500

Excess Return

+45.75 pts

Relative to SPY

ARGNF Max Drawdown

-18.37%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

ARGNFSPY

Calendar-Year Returns

Uses the longest available daily history for ARGNF and SPY.

YearARGNFSPYExcessLeader
2026+3.45%+6.71%-3.26 ptsSPY
2025+59.00%+11.19%+47.80 ptsARGNF

Unable to load analyst forecasts.

Timed out loading forecasts for ARGNF

Next Step

Put consensus data in context

Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.